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Abstract
Methyl CpG binding protein-2 (MeCP2) is an essential epigenetic regulator in human brain development. Mutations in the
MeCP2 gene have been linked to Rett syndrome, a severe X-linked progressive neurodevelopmental disorder, and one of
the most common causes of mental retardation in females. MeCP2 duplication and triplication have also been found to
affect brain development, indicating that both loss of function and gain in MeCP2 dosage lead to similar neurological
phenotypes. Here, we used the Xenopus laevis visual system as an in vivo model to examine the consequence of increased
MeCP2 expression during the morphological maturation of individual central neurons in an otherwise intact brain. Single-
cell overexpression of wild-type human MeCP2 was combined with time-lapse confocal microscopy imaging to study
dynamic mechanisms by which MeCP2 influences tectal neuron dendritic arborization. Analysis of neurons co-expressing
DsRed2 demonstrates that MeCP2 overexpression specifically interfered with dendritic elaboration, decreasing the rates of
branch addition and elimination over a 48 hour observation period. Moreover, dynamic analysis of neurons co-expressing
wt-hMeCP2 and PSD95-GFP revealed that even though neurons expressing wt-hMeCP2 possessed significantly fewer
dendrites and simpler morphologies than control neurons at the same developmental stage, postsynaptic site density in wt-
hMeCP2-expressing neurons was similar to controls and increased at a rate higher than controls. Together, our in vivo
studies support an early, cell-autonomous role for MeCP2 during the morphological differentiation of neurons and indicate
that perturbations in MeCP2 gene dosage result in deficits in dendritic arborization that can be compensated, at least in
part, by synaptic connectivity changes.
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Introduction
Methyl-CpG binding protein 2 (MeCP2) is a DNA binding
protein encoded by a gene located on chromosome Xq28 in
humans, and is a protein that is evolutionarily conserved both in
structure and in function. Mutations in the Mecp2 gene have been
linked to Rett syndrome in humans (RTT) [1], a severe X-linked
progressive neurodevelopmental disorder and one of the most
common causes of mental retardation in females. Moreover, Mecp2
duplication and triplication have been found in males with severe
mental retardation [2,3,4,5], indicating that both loss of function
and gain in MeCP2 dosage lead to similar neurological
phenotypes. In addition to its role in formation and maturation
of neuronal circuits, MeCP2 has been implicated in neuronal
specification during early embryogenesis in several species,
including Xenopus [6,7]. Specifically, studies show that MeCP2
can regulate neuronal precursor cell number by modulating
transcription of the neuronal repressor xHairy in the dif-
ferentiating neuroectoderm of early Xenopus embryos [6]. Thus,
it is likely that in Xenopus, as in other vertebrate species, MeCP2
participates in both early and late aspects of central neuron
development.
Rett syndrome is characterized by an early developmental loss
of motor skills and language, mental retardation, and autistic
behaviors. Significant alterations in dendritic arborization and in
dendritic spine number observed in brain samples of Rett patients
have led to the hypothesis that developmental defects in synaptic
connectivity may be responsible, at least in part, for the deficits
caused by this genetic disorder [8]. The onset of RTT in infants
occurs before 18 months of age, which corresponds to the time of
active synaptogenesis in the brain. Similarly, in rodents, MeCP2
expression in the brain closely correlates with the onset of neuronal
maturation and synaptogenesis [9,10,11,12,13], supporting the
notion that MeCP2 may be involved in the formation and/or
maturation of synaptic circuits. Studies using mouse models of the
disease show that alterations in MeCP2 expression affect dendritic
and axon arbor structure, and can also influence both the
formation and functional properties of synapses in specific areas of
the brain (for review see [14,15]). Although studies using mouse
models of Rett syndrome have proven to be key in identifying
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possible targets of MeCP2, they often involve mutations and/or
manipulations affecting a large population of neurons and/or non-
neuronal cells [11,16,17,18,19,20,21,22,23,24,25,26,27,28], thus
making it difficult to differentiate between causality and compen-
satory effects. In this study, we used the Xenopus visual system as an
in vivo model to examine potential cell autonomous effects of
altered MeCP2 expression on developing central neurons. Our
studies show that MeCP2 is expressed in the visual system of
Xenopus tadpoles at the time that functional synaptic connections
are formed. Moreover, using time-lapse confocal microscopy
imaging at the onset of synaptogenesis we demonstrate that
overexpression of wild-type human MeCP2 significantly interfered
with the elaboration of the dendritic arbor in the individually
affected tectal neurons in swimming tadpoles. In vivo time-lapse
imaging of neurons co-expressing fluorescently-tagged synaptic
proteins also revealed that MeCP2 overexpression differentially
influences dendritic arborization and postsynaptic site differenti-
ation. Together, our in vivo studies support an early, cell-
autonomous role for MeCP2 during the morphological differen-
tiation of Xenopus central neurons and indicate that increases in
MeCP2 gene dosage result in deficits in dendritic growth that can
be compensated, at least in part, by an upregulation in synapse
number.
Materials and Methods
Animals
Ethics statement. Animal procedures were approved by the
Institutional Animal Care and Use Committee of the University of
California, Irvine (Animal Welfare Assurance Number A3416-01).
Xenopus laevis tadpoles were obtained by in vitro fertilization of
oocytes from adult females primed with human chorionic
gonadotropin (Sigma-Aldrich, St Louis, MO). Tadpoles were
raised in rearing solution [60 mM NaCl, 0.67 mM KCl, 0.34 mM
Ca(NO3)2, 0.83 mM MgSO4 10 mM HEPES, pH 7.4, and
40 mg/L gentamycin] plus 0.001% phenylthiocarbamide to
prevent melanocyte pigmentation. Tadpoles were anesthetized
during experimental manipulations with 0.05% tricane
methanesulfonate (Finquel; Argent Laboratories, Redmond,
WA). Staging was done according to Nieuwkoop and Faber [29].
RNA extraction, cDNA synthesis and RT-PCR
The midbrains and retinas of stage 40 and 45 Xenopus tadpoles
were dissected out, individually collected and homogenized in
500 ml ice-cold Trizol (Life technologies, Carlsbad, CA). After
chloroform extraction and isopropyl alcohol precipitation, total
RNA was dissolved in 25 ml RNase-free dH2O, and the total RNA
was measured with a DU 530 life science UV/VIS spectropho-
tometer (Beckman Coulter, Brea, CA). First strand cDNA was
synthesized from 0.1 mg total RNA using the Superscript First-
Strand Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA)
according to the manufacturer’s instructions. RT-PCR was
performed in a total volume of 25 ml in buffer containing 5 ml
cDNA (diluted 56), 3 mM MgCl2, 0.2 mM dNTPs, 1 U of
Platinum high fidelity Taq polymerase (Invitrogen) and 0.3 mM of
each primer. Trans-intron primers were designed for MeCP2
(accession No. AF106951) and GAPDH (accession No. U41753)
to control for the presence of genomic DNA, with the following
sequences: MeCP2, forward 59-CTTCCTGAAGGCTGGA-
CACG-39 and reverse 59-GGAAGTATGCTATAAGCTCAAC-
39; GAPDH, forward 59-GCTCCTCTCGCAAAGGTCAT-39
and reverse 59-GGGCCATCCACTGTCTTCTG-39. The fol-
lowing thermal profile was used: 95uC for 30 s, 60uC for 30 s and
72uC for 2 min, using a programmable thermal cycler iCycler
(Bio-Rad laboratories, Hercules, CA). The PCR products were
separated on a 2% agarose gel and visualized with ethidium
bromide. No contamination with genomic DNA was observed.
DNA constructs and plasmid transfections
cDNA coding for human wild type MeCP2 (hMeCP2) was
kindly provided by Dr. I. Stancheva (University of Edinburgh,
Edinburgh, UK). A hMeCP2-pCS2 plasmid was created by
subcloning hMeCP2 cDNA into a pCS2+ expression vector under
control of the cytomegalovirus (CMV) promoter. A hMeCP2-
IRES-GFP bicistronic plasmid was created by subcloning
hMeCP2 cDNA into a pIRES2-EGFP vector (Clontech, Palo
Alto, CA). A plasmid coding for a red fluorescent protein variant
(pDsRed2, Clontech, Palo Alto, CA) was used to visualize the
morphology of tectal neurons transfected with hMeCP2 plasmids.
In a first set of studies, the hMeCP2-IRES-GFP construct
(MeCP2-IRES group), or a control pIRES2-EGFP construct
(IRES-GFP control group) were co-transfected with the pDsRed2
plasmid. Lipofection of a 1:1 mix of the DsRed2 and IRES
plasmids into the brain primordium of stage 20–22 tadpoles was
performed in as previously described [30]. Tadpoles were reared
until stage 45, when tadpoles with neurons co-expressing both
DsRed2 and GFP were selected for imaging. Following imaging,
retrospective immunostaining with an antibody against human
MeCP2 (Upstate, Lake Placid, NY) was used to further confirm
hMeCP2 expression in neurons transfected with hMeCP2-IRES-
GFP (see below). In a second set of experiments, expression of a
plasmid that encodes the postsynaptic density protein 95 (PSD-95)
fused to GFP (PSD95-GFP) [30] was used to visualize postsynaptic
specializations in hMeCP2 expressing neurons. Specifically,
neuronal precursor cells in brain primordia of stage 20–22
tadpoles were co-lipofected with a mix of DsRed2, PSD95-GFP
and hMeCP2-CS2 plasmids (1:1.5:2 molar ratio in DOTAP) to
follow changes in GFP-labeled postsynaptic sites in hMeCP2
expressing neurons. As controls, neurons were lipofected with
only DsRed2 and GFP-PSD95 in stage 20–22 tadpoles. At stage
45, tadpoles with individual DsRed2 and PSD95-GFP double-
labeled tectal neurons were selected for time-lapse imaging.
Following the last imaging session, retrospective immunostaining
was used to confirm expression of hMeCP2 in the PSD95-GFP/
DsRed2 positive neurons. Previous electron microscopy and
immunohistochemical studies demonstrated that PSD95-GFP
specifically localizes to ultrastructurally-identified retinotectal
synapses in Xenopus, and to synaptic vesicle rich contact sites
in vivo [30].
In vivo time-lapse imaging
The branching of individual fluorescently-labeled tectal neurons
was followed by confocal microscopy in stage 45 tadpoles.
Tadpoles containing individual, clearly distinguishable double-
labeled neurons were anesthetized and imaged every 24 h for two
days (time points 0 h, 24 h and 48 h). Images were acquired using
LSM 5 Pascal confocal microscope with a 663/0.95 water
immersion objective. Optical sections were collected at 1 mm
intervals.
Data analysis
All analysis was performed from raw confocal images without
any post-acquisition manipulation or thresholding. Digital three-
dimensional reconstructions of DsRed2-labeled dendritic arbors
were obtained from individual optical sections through the entire
extent of the arbor with the aid of the MetaMorph software
(Molecular Devices, Sunnyvale, CA). To characterize the
MeCP2 Interferes with Dendrite Elaboration
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pixel-by-pixel overlaps of individual optical sections obtained at
the two wavelengths were analyzed as described previously [30].
Several morphological parameters were measured for the
quantitative analysis of dendritic branching: total branch number,
the number of individual branches added and the number of
branches remaining from one observation time point to the next
(stable branches). Total arbor length was measured from binarized
images of the digitally reconstructed dendritic arbors and was
converted to microns. To determine dendrite length distribution
and the outermost extent of the dendritic arbor, digitally
reconstructed dendritic arbors were submitted to Sholl analysis.
The length of the longest dendrite was determined as the radius
value of the circle with its circumference intersecting with the
furthest extending dendrite. The number of 1
st,2
nd,3
rd and 4
th
order branches in each individual dendritic arbor was measured
and used to calculate Dendritic Complexity Index (DCI) as
described previously [31]. As outlined above, two sets of
experiments were performed, each with its own controls. As
controls, neurons co-expressing IRES-GFP/DsRed2 and or
PSD95-GFP/DsRed2 were analyzed. No significant difference
was found in any of the parameters examined between the two
control groups analyzed (IRES-GFP/DsRed2, n=11 vs PSD95-
GFP/DsRed2, n=19), or between neurons transfected with the
two distinct hMeCP2 expression plasmids (hMeCP2-IRES-GFP,
n=11 vs MeCP2-CS2, n=17). Therefore, data from both control
groups and data from both hMeCP2 overexpressing groups was
combined for the analysis of branch morphology and dynamics.
For the analysis of postsynaptic specializations in expressing
neurons, GFP-labeled postsynaptic clusters were counted for each
dendritic arbor in the hMeCP2-CS2/PSD95-GFP/DsRed2 trans-
fected neurons and in the corresponding controls. T-tests were used
for the statistical analysis of data. Results were considered
significant as follows: *p#0.05, **p#0.005, ***p#0.0005.
Immunohistochemistry
For visualization of exogenous hMeCP2 expression, immedi-
ately after the last imaging session, tadpoles transfected with
DsRed2 and hMeCP2-IRES-GFP plasmids or with DsRed2,
PSD95- GFP and hMeCP2-CS2 plasmids were anesthetized and
fixed for 2 hr by immersion in 2% paraformaldehyde in 0.1 M
phosphate buffer (PB), pH 7.4. Following fixation, brains were
removed and postfixed with the same fixative for an additional
hour at room temperature. Free-floating brains were preincubated
for 1 hr in blocking solution (1.5% normal goat serum and 0.1%
Triton X-100 in 0.1 M PB) and incubated overnight with a rabbit
polyclonal anti-human MeCP2 antibody (1:500 dilution; Upstate,
Lake Placid, NY). Tissues were then rinsed and incubated with
Alexa 633 anti-rabbit antibodies (1:200 dilution 0.1 M PB;
Invitrogen). All images were collected with a LSM 5 Pascal
confocal microscope (Zeiss, Jena, Germany) using a 663/1.4
numerical aperture oil immersion objective, at 1 mm intervals. For
visualization of endogenous MeCP2, stage 40 tadpoles were fixed
as described above. Twenty-micron cryostat sections were
obtained, preincubated for 1 hr in blocking solution (1.5% normal
goat serum and 0.1% Triton X-100 in 0.1 M PB) and incubated
overnight with rabbit polyclonal anti-MeCP2 antibody (1:100
dilution; Upstate, Lake Placid, NY) together with a monoclonal
antibody against the Vesicle Associated Membrane Protein-2
(VAMP-2) (1:1000 dilution, QED Bioscience Inc, San Diego, CA).
Following washes, sections were incubated with anti-rabbit Alexa
488 and anti-mouse Alexa 568 secondary antibodies (Invitrogen;
1:500 dilution).
Results
MeCP2 is expressed in the developing visual system of
Xenopus tadpoles
Here, we used Xenopus as an in vivo model system in which
manipulations in gene expression can be spatially and temporally
controlled to examine the consequence of altered MeCP2
expression during the morphological maturation of central
neurons. MeCP2 is expressed in the neuroectoderm of Xenopus
embryos, where it plays an essential role in early neurogenesis by
controlling the expression of proteins downstream of proneural
genes [6]. To determine if MeCP2 expression is maintained in
Xenopus central neurons at the time they differentiate and establish
synaptic connections, we analyzed MeCP2 mRNA expression in
the visual system of swimming tadpoles by RT-PCR. We found
that MeCP2 mRNA is expressed both in the retina and optic
tectum of stage 40 and stage 45 tadpoles (Fig. 1A), at the time that
retinal ganglion cell axons project to and establish functional
synaptic connections with their target neurons in the optic tectum
[32,33,34]. Immunostaining with an anti-human MeCP2 antibody
that, although weak, shows cross-species immunoreactivity with
Xenopus confirmed MeCP2 protein expression in neurons in the
retina and optic tectum at these developmental stages (Fig. 1B).
Thus, endogenous MeCP2 is expressed by Xenopus central neurons
at the time they begin to differentiate and receive functional
synaptic inputs.
Overexpression of hMeCP2 interferes with tectal neuron
dendritic arborization
To examine the impact of altered MeCP2 expression during the
morphological and synaptic maturation of central neurons, we
overexpressed wild-type human MeCP2 cDNA in tectal neurons
in live Xenopus tadpoles. Targeted co-transfection of plasmids into
the developing midbrain of young tadpoles allowed us to increase
MeCP2 levels in single tectal neurons as they begin to differentiate,
and to examine their morphology at the time they actively branch
and establish synaptic contacts in intact tadpoles (stage 45).
Dendritic arbor morphology was visualized by expressing DsRed2
together with hMeCP2 (see Methods and Fig. 1 C, D and Fig. 2).
An IRES-GFP expression plasmid (hMeCP2-IRES-GFP) was used
to express hMeCP2 and to confirm its expression in vivo by the
independent expression of the GFP marker (Fig. 1 D, Fig. 2 C, D).
Alternatively, in a second set of experiments, an expression
plasmid coding for wt-hMeCP2 alone was co-transfected with a
plasmid coding for GFP-tagged postsynaptic density protein PSD-
95 (PSD-95-GFP) and the DsRed2 plasmid. The latter manipu-
lation allowed us to visualize GFP-labeled postsynaptic specializa-
tions in a subset of neurons expressing hMeCP2 (Fig. 1C).
Retrospective immunostaining with an anti-human MeCP2
antibody confirmed expression of hMeCP2 in the triple
(DsRed2/PSD95-GFP/hMeCP2), and double (DsRed2/
hMeCP2-IRES-GFP), transfected neurons (Fig. 1 C, D).
In vivo confocal microscopy imaging of tectal neurons expressing
hMeCP2 revealed that MeCP2 overexpression significantly altered
the morphological differentiation of neurons. At stage 45, tectal
neurons expressing hMeCP2 possessed significantly fewer den-
drites than control neurons in tadpoles at the same developmental
stage (Fig. 2, Fig. 3A). On average, tectal neurons expressing
hMeCP2 possessed significantly fewer dendritic branches than
controls (Control 18.1761.23 total branches n=30 neurons, one
neuron per tadpole, MeCP2 11.3261.45 total branches, n=28
neurons, one neuron per tadpole; p=0.0007, Fig. 3A). To further
determine the impact of MeCP2 overexpression on dendritic
branching, neurons were imaged again 24 and 48 hours after the
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elaborate over time by the dynamic addition and retraction of
dendritic branches (see Fig. 2 A, B and also [30,33]). These
dynamic changes in dendritic branching result in arbors with
significantly more branches over a 48 hour period (Fig. 3A).
Expression of hMeCP2 in single tectal neurons, in contrast,
significantly interfered with dendritic arbor growth (Fig. 2 C, D,
Fig. 3A). No significant change in total branch number was
observed in MeCP2 overexpressing neurons between any of the
observation intervals while in controls, a close to 50% increase in
branch number was observed in a 48 hour period (Controls;
18.1761.23 total branches at 0 hr, 28.5061.9 at 48 hr,
p=0.0001; MeCP2 11.3261.45 branches at 0 hr, 13.0761.95
at 48 hr, p=0.47; Fig. 3A). Thus, hMeCP2-expressing neurons
remained relatively simple over time.
Similar to its effect on branch number, total arbor length was
significantly lower in the hMeCP2- expressing neurons than in
control neurons in stage 45 tadpoles (Control 328.7626.68 mm,
MeCP2 202.0618.99 mm, p=0.0004; Fig. 3B). Total dendritic
arbor length remained significantly lower in the hMeCP2-
expressing neurons 24 and 48 hours after the first imaging when
compared to control neurons (Fig. 3B). The length of the dendritic
arbor of hMeCP2-expressing neurons increased over time, a
difference that almost reached significance within 48 hours after
initial imaging (dendrite arbor length 202.9618.99 mm at 0 hr;
278.2638.0 mm at 48 hr, p=0.0551; Fig. 3B). The observation
that MeCP2 overexpression negatively affects branch number
more than arbor length suggested that overall, the extended
dendritic branches in hMeCP2-expressing neurons may be longer
in length. Indeed, a relative measure of dendritic segment length,
calculated as the ratio of total arbor length by total branch
number, showed that on average branches were longer in
hMeCP2-expressing neurons than in control neurons at the same
developmental stage (Control 18.5261.10 mm/branch at stage 45,
t=0, MeCP2 27.2264.356 mm/branch at stage 45, t=0;
p=0.0411; Fig. 3C). Sholl analysis also revealed that while
dendritic processes were fewer, they were widely distributed along
the arbor in the hMeCP2-expressing neurons (Fig. 3D), with the
maximal extent of the dendrites in the neurons overexpressing
MeCP2 not differing from controls (Control 75.0065.378 mma t
Figure 1. Expression of MeCP2 in the developing Xenopus laevis visual system. (A) Endogenous expression of Xenopus MeCP2 mRNA in the
tectum and retina of stage 40 and stage 45 Xenopus tadpoles is shown by the RT-PCR reaction products. A single band of the expected molecular
weight was observed. Expression of the housekeeping gene x-GAPDH is also shown for comparison. DNA molecular weight markers are shown to the
left (M, in base pairs). (B) MeCP2 protein expression in the retina and optic tectum of Stage 40 tadpoles. Left panel: MeCP2 immunopositive cells
(green) are localized to the ganglion cell layer (gcl) and inner nuclear layer (inl) of the developing retina. The retinal synaptic layers are shown by the
immunostaining with an antibody to VAMPII (red). Right panel: Coronal section of a stage 40 tadpole at the level of the optic tectum shows MeCP2
expression in neurons (green) close to the tectal neuropil (n), which is visualized by VAMPII immunostaining (red). V=ventricle. Scale bar=500 mm. (C,
D) Transfection with human wild-type hMeCP2 constructs was used to alter expression of MeCP2 in postmitotic Xenopus tectal neurons at the onset
of synaptic differentiation. C) Expression of wt-hMeCP2 was confirmed in triple transfected neurons co-expressing DsRed2, PSD-95-GFP and wt-
hMeCP2 as illustrated here by the overlaid live confocal image (overlay), and the red (DsRed2) and green (PSD95-GFP) fluorescence as well as the
MeCP2 immunofluorescence (blue) after fixation. D) Tectal neuron transfected with DsRed2 and a wt-hMeCP2-IRES-GFP plasmid. Live confocal
imaging shows colocalization of DsRed2 (red) and GFP (green) in the nucleus, cell body, and primary dendrite. Retrospective immunostaining with an
antibody directed to human wild-type MeCP2 shows the localization of the MeCP2 protein to the nucleus and proximal portion of the primary
dendrite (blue). Scale bar for C, D=10 mm.
doi:10.1371/journal.pone.0033153.g001
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p=0.968). Thus, the increase in dendrite arbor length but not
branch number indicates that although MeCP2 overexpression
mainly interfered with dendritic branch initiation, it did not
completely interfere with the ability of individual dendrites to
lengthen.
To obtain an additional measure of the effect of MeCP2
overexpression on dendritic branching, we determined the
proportion of primary, secondary and tertiary branches in neurons
expressing hMeCP2 and compared it to controls. Analysis of
branch order distribution at the initial observation time point
(stage 45, t=0) showed that in proportion, hMeCP2-expressing
neurons had significantly fewer tertiary branches than controls (3
rd
order branches: Controls 40.5363.34%, MeCP2 23.4263.14%,
p=0.0007; Fig. 4A), extending mostly primary and secondary
branches (1st order branches: Controls 7.88961.70%, MeCP2
20.3164.84%, p=0.045; Fig. 4A). Thus MeCP2 overexpression
resulted in neurons with simpler dendritic arbors than controls. To
further determine the effect of MeCP2 overexpression on dendritic
branching over time, we evaluated dendritic arbor complexity by
assigning a topological order to every branch in each individual
dendritic arbor and by calculating a Dendritic Complexity Index
(DCI) using the formula described in Fig. 4B. DCI provides an
additional relative measure of branch order number [31]. At the
initial observation time point, MeCP2-expressing neurons pos-
sessed a DCI value lower than controls (controls 1.5260.076,
MeCP2 1.2660.066, p=0.013; Fig. 4B), indicating a simpler
dendritic arbor complexity. Moreover, within 48 hours, control
neurons significantly increased their DCI value (DCI controls:
t=0 hr 1.5260.076, t=48 hr 1.8160.069, p=0.017; Fig. 4B)
and branch order number (Fig. 4C), whereas in MeCP2
overexpressing neurons DCI values and branch order number
(Fig. 4D) did not change over a 48 hour period. Thus, as a
consequence, MeCP2 neurons were simpler in morphology, with
fewer high-order branches, but with primary and secondary
branches that were normal in length. Together, our data
demonstrates that MeCP2 overexpression interferes with the
ability of tectal neurons to arborize and to increase the
morphological complexity of their dendritic arbor.
Overexpression of MeCP2 affects new branch addition
Developing tectal neurons significantly increase dendritic
branch number and complexity by stabilizing a large portion of
their branches and by adding new branches while also eliminating
some of the existing branches [30,33,35,36]. To further examine
the effects of MeCP2 overexpression on dendritic branch
dynamics we analyzed whether hMeCP2 expression altered the
addition, elimination and/or stability of individual dendritic
branches over time. Analysis of branch dynamics revealed that
hMeCP2-expressing neurons continued to add new branches
during every 24 hour imaging interval, although fewer in number
than control neurons (Added branches: Control 13.7961.149
branches/24 h, MeCP2 5.45960.7833 branches/24 h; p,0.0001,
Fig. 5A). Similarly, the proportion of added branches (percent of
total branches) in hMeCP2-expressing neurons was also signifi-
cantly lower than in controls (Added branches: Control
57.1362.75%, MeCP2 37.6263.51%, p=0.001; Fig. 5B). Time-
lapse imaging also revealed that as many branches were eliminated
in hMeCP2-expressing neurons as were added within a 24 hour
period (MeCP2: 5.45960.7833 branches added, 4.5060.762
branches eliminated, p=0.386), while in controls significantly
more branches were added than eliminated thus promoting
growth (Control: 13.7961.149 branches added, 10.1460.846
branches eliminated, p=0.012; for branches eliminated in
hMeCP2-expressing neurons vs. controls, p,0.0001; not shown
graphically). Moreover, analysis of branch dynamics revealed that
even though MeCP2 overexpressing neurons possessed relatively
fewer branches that were stabilized than control neurons at the
same developmental stage (Stable branches: Control 9.42960.62,
MeCP2 6.51460.58, Fig. 2 and Fig. 5A), in proportion, those
existing branches were significantly stable (Control 49.1662.45%,
Figure 2. Expression of hMeCP2 influences tectal neuron dendritic branching. (A, B) Sample tectal neurons expressing DsRed2 (red)
together with GFP (green; IRES-GFP construct) from stage 45 Xenopus tadpoles illustrate the morphologies and dynamics of tectal neuron dendritic
branching over time. (C, D) Tectal neurons expressing DsRed2 (red) and wt-hMeCP2-IRES-GFP (green) in stage 45 Xenopus tadpoles illustrate the
effects of MeCP2 overexpression on dendritic morphology and branch dynamics. In these confocal projections, GFP expression (yellow; green and red
overlay) confirms the expression of wt-hMeCP2. The asterisks mark a primary dendrite and axons are demarcated by the arrows. Scale bar=20 mm.
doi:10.1371/journal.pone.0033153.g002
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lower branch addition and elimination rates observed in hMeCP2-
expressing neurons indicates that MeCP2 overexpression results in
dendritic arbors that are morphologically simpler and less
dynamic, but that are able to retain stably those few branches
that are initially extended.
MeCP2 overexpression increases postsynaptic
specialization density in tectal neuron dendritic arbors
Previous studies demonstrate that developing neurons establish
synapses in a dynamic way, and that synapse formation coincides
with the active elaboration and branching of the neuron’s
dendritic arbor. To further establish a potential relationship
between synapse formation and dendritic elaboration in response
to altered MeCP2 expression, we used single cell co-transfection of
wt-hMeCP2, DsRed2 and PSD95-GFP expression plasmids in live
Xenopus embryos. PSD95-GFP specifically localizes to synaptic
contact sites in vivo and to ultrastructurally identified synapses in
tectal neuron dendrites [30]. Thus, this allowed us to visualize
postsynaptic specializations in single neurons overexpressing
MeCP2 in an otherwise intact brain (Fig. 6). Because dendritic
arbors in MeCP2 expressing neurons were overall simpler, the
total number of postsynaptic specializations in MeCP2 neurons
was significantly lower than controls at stage 45, the initial
observation time (t=0 hr: Control 53.43610.12; MeCP2
16.8363.04, p=0.008, Fig. 6, Fig. 7A). Our imaging studies
revealed, however, that although hMeCP2-expressing neurons
possessed fewer dendritic branches, the density of postsynaptic
specializations, measured as the number of PSD95-GFP puncta
per mm of arbor length, was similar to controls (Control
1.05960.06, MeCP2 1.16960.186, p=0.531, Fig. 7B). To
support the observation that MeCP2 overexpression indeed
influences postsynaptic density, we compared the morphology
and PSD95-GFP cluster density in hMeCP2-expressing neurons
(stage 45) with that of control neurons of stage 43 tadpoles
(24 hours earlier) that more closely matched the maturational state
of neurons overexpressing MeCP2 at stage 45. Postsynaptic
specialization density in hMeCP2-expressing neurons at stage 45
was significantly higher than that of control tectal neurons in
younger tadpoles (Stage 43 controls 0.793960.04 PSD95-GFP
Figure 3. Quantitative analysis of changes in dendritic arbor morphology induced by overexpression of wild-type hMeCP2. (A) Total
number of branches in tectal neurons of stage 45 Xenopus tadpoles at the initial observation time point, and 24 and 48 hours after initial imaging.
Note that control neurons increased their total number of branches over a 48 hr period, while wt-hMeCP2 expressing neurons had significantly fewer
branches and failed to increase branch number over time. (B) Total dendritic arbor length remained significantly lower in MeCP2 overexpressing
neurons, while control neurons increase their total dendritic arbor length in every 24 hr observation interval. (C) A relative measure of dendritic
segment length, calculated as the ratio of total arbor length by total branch number, shows that on average branches in hMeCP2-expressing neurons
are longer than in controls. (D) Left; Sholl analysis was used to determine the number of dendritic crossings in MeCP2 overexpressing and control
neurons at 0 hours as measure of dendrite morphology and length. Note that while the maximal extent of the dendritic arbor is similar in hMeCP2-
expressing neurons and controls, hMeCP2-expressing neurons have a more uniformly distributed pattern of dendrite lengths. Significance * p#0.05;
** p#0.005, ***p#0.001.
doi:10.1371/journal.pone.0033153.g003
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puncta per mm, p=0.0145). Tectal neurons of stage 43 tadpoles
possessed dendritic arbors with branch numbers and total dendrite
arbor length similar to the hMeCP2-expressing neurons at stage
45 (Stage 43 control; branch number 11.8360.8717, total arbor
length 233.4614.53, n=18 neurons, see Fig. 3A), therefore
postsynaptic specialization density was significantly higher in
MeCP2 expressing neurons than their maturation matched
controls. Moreover, time-lapse imaging revealed that the number
and density of postsynaptic specializations in MeCP2 overexpress-
ing neurons increased significantly over time (PSD95-GFP cluster
number: t=0h r16.8363.04; t=24 hr 35.8365.22; p=0.0104;
t=48 hr 41.0069.29, p=0.0149, Fig. 7 A, B), and at a rate higher
than their age-matched controls (stage 45; Fig. 7C). This
significant increase in PSD95-GFP puncta in the MeCP2
expressing tectal neurons as they develop over time suggests the
existence of mechanisms that take effect to compensate for a
morphologically simpler dendritic arbor.
Discussion
In this study, we used the developing Xenopus retinotectal system
as an in vivo model to examine cell autonomous effects of MeCP2
expression during the morphological maturation of individual
central neurons in an otherwise intact brain. Our results show that
a gain in MeCP2 function, achieved by the expression of wild-type
human MeCP2 above the endogenous Xenopus MeCP2 expression,
interfered with the morphological differentiation of tectal neuron
Figure 4. hMeCP2-expressing neurons develop morphologically simple dendritic arbors. (A) The complexity of the dendritic arbors in
control neurons expressing DsRed2 and in neurons co-expressing DsRed2 and hMeCP2 is exemplified by the proportion of first, second, third and
fourth order branches, expressed as percent of their total branch number. Note that MeCP2 overexpressing neurons have proportionately more first
order branches but fewer third order branches. (B) Top; The Dendritic Complexity Index (DCI) provides an additional measure of dendritic
morphology. Bottom graph; The DCI value for MeCP2 expressing neurons was significantly lower than the value for control neurons at the initial
observation time point. Moreover, while control neurons significantly increased their DCI value by 48 h, DCI value for hMeCP2-expressing neurons did
not change over time. C, D) Branch order distribution at 0 and 48 hours for (C) control, and (D) hMeCP2-expressing neurons. Note the significant shift
in distribution of branches in control neurons, indicating an increase in complexity over time, while no change was observed over a 48 hour period in
neurons overexpressing MeCP2. Significance * p#0.05; ** p#0.005, ***p#0.001.
doi:10.1371/journal.pone.0033153.g004
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postsynaptic specializations on the few dendrites that developed
and remained stable. These changes in dendritic arbor elaboration
and postsynaptic differentiation occurred at the time when
neurons begin to branch and differentiate, and were sustained
throughout the imaging period. Therefore, cell-specific alterations
in MeCP2 expression are sufficient to impact the connectivity and
function of neurons in the developing, living brain.
Mutations in the MeCP2 gene, loss of gene function, as well as
increased MeCP2 gene copy number have been associated with
neurodevelopmental defects that lead to Rett syndrome and
mental retardation [1,2,3,4,5]. Anatomical post-mortem data in
humans reveal that alterations in MeCP2 expression lead to
changes in synaptic number and in neuronal morphology in
affected brains [8,37]. Both transgenic and knockout mouse
models have provided important information for understanding
how MeCP2 miss-expression affects brain development and
function [16,17,18,19]. However, confounding or opposing results
have been obtained amongst some studies that seem to
depend on the particular mutation or analysis performed
[11,20,21,22,23,24,25,26,27,28]. For example, studies have re-
ported a decrease in dendritic branch complexity upon MeCP2
downregulation in vivo and in culture [11,23,28,38] while others
show no effect of decreased MeCP2 expression on neuronal
complexity [21,25]. Interestingly, both downregulation and
overexpression of MeCP2 in knockout and transgenic mice have
Figure 5. Overexpression of MeCP2 decreases new branch formation in developing tectal neurons but does not interfere with the
stability of existing branches. The absolute (A) and relative (B) number of stabilized and newly added branches in MeCP2 overexpressing
neurons compared to controls are shown by the bar graphs. hMeCP2-expressing neurons added significantly fewer new branches than controls
during every 24 imaging period (0–24 h and 24–48 h, combined). As percentage, the number of dendritic branches stabilized over a 24 h period is
significantly higher in hMeCP2-expressing neurons than controls (B), although hMeCP2-expressing neurons had fewer dendritic branches overall (A,
absolute values; see also Fig. 3). Significance * p#0.05; ** p#0.005, ***p#0.001.
doi:10.1371/journal.pone.0033153.g005
Figure 6. Postsynaptic site differentiation in hMeCP2-expressing tectal neurons. Time lapse confocal images of representative control (A,
B) and hMeCP2-expressing (C, D) tectal neurons co-expressing DsRed2 (red) and PSD95-GFP (green) in stage 45 Xenopus tadpoles illustrate the
morphologies and distribution of PSD95-GFP postsynaptic specializations (yellow puncta; red and green overlap) on the dendritic arbors. (C, D) Tectal
neurons co-expressing wild-type hMeCP2 together with DsRed2 and PSD95-GFP show an increase in the density of postsynaptic clusters (yellow
puncta, arrowheads) over a 24 and 48 h observation period. Axons of tectal neurons are marked by white arrows. Expression of hMeCP2 was
confirmed by retrospective immunostaining as in Fig. 1D. Scale bar=20 mm.
doi:10.1371/journal.pone.0033153.g006
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neurons in similar ways, suggesting that threshold levels of MeCP2
expression are required for the maintenance of dendritic arbor
structure [28]. Here, by examining the early, dynamic effects of
MeCP2 overexpression in single Xenopus central neurons in vivo we
demonstrate that MeCP2 regulates different aspects of neuronal
maturation and of synaptogenesis in a cell autonomous way. The
observation that individual Xenopus tectal neurons overexpressing
MeCP2 are morphologically less mature at the time of active
dendritic elaboration than control neurons at the same develop-
mental stage is consistent with observations that MeCP2
overexpression negatively influences the branching of mouse
hippocampal neurons in culture [28]. Tectal neurons expressing
wt-hMeCP2 had significantly less branches than controls and
remained simple over the course of 48 hours of imaging. However,
even though neurons overexpressing MeCP2 failed to increase
dendritic branch complexity over time, the extended dendrites
retained the ability to elongate. Thus, in the developing Xenopus
visual system, altered level of MeCP2 expression and function
impact the morphological maturation of tectal neurons by
interfering with dendrite branching but not dendrite growth.
Effects of altered MeCP2 expression on synapse density and
function have been described for multiple neuronal populations in
animal model systems [15,39,40]. Observations of altered synaptic
connectivity in models of Rett syndrome correlate with observa-
tions of decreased dendritic spine number and loss of spines in the
cortex in brains of subjects with RTT [8,37,41,42]. In our study,
we also examined the effects of MeCP2 overexpression on the
ability of central neurons to form synaptic specializations on their
dendrites. Our results demonstrate that even though dendritic
arbors in individual neurons expressing hMeCP2 were less
branched, the density of postsynaptic specializations, as visualized
by the punctate accumulation of PSD-95-GFP, remained similar
to those observed for control neurons in the intact brain.
Importantly, time-lapse imaging revealed that neurons overex-
pressing MeCP2 increased the rate at which postsynaptic
specializations continued to form. These results therefore indicate
that gain of MeCP2 function interferes with dendrite initiation and
branching, thus resulting in deficits in overall dendritic growth, but
that these deficits in connectivity can be compensated, at least in
part, by an increase in synapse number on the stunted dendrites.
In agreement with our observation that synapse density is
gradually increased in tectal neurons overexpressing MeCP2 are
studies demonstrating that in hippocampal neurons of transgenic
mice in which MeCP2 dosage is doubled, the density of
glutamatergic synapses is increased even though dendritic
branching and length are unchanged [21]. Thus, consistent with
observations in mammals [21], MeCP2 influences the synaptic
maturation of neurons independent of its effects on dendritic arbor
morphology and growth, allowing for compensatory mechanisms
that adjust synaptic inputs to dendrite arbor geometry to maintain
structural homeostasis [43].
In the Xenopus visual system, MeCP2 is expressed in both the
retina and the optic tectum at the time of active retinotectal circuit
formation and at the time when functional synaptic connections
are formed. The observation that MeCP2 is expressed in the
retinotectal system of this species is consistent with previous
findings demonstrating high MeCP2 expression in early Xenopus
embryos [6] and in the embryonic and adult zebrafish brain [7].
Hence, MeCP2 can play multiple roles during the formation and/
or maturation of neuronal circuits in the vertebrate nervous
system. In Xenopus, MeCP2 can regulate neuronal precursor cell
number by modulating transcription of the neuronal repressor
xHairy in the differentiating neuroectoderm early during embryo-
genesis [6]. MeCP2 is also considered to be a regulator of global
chromatin architecture in the cell, where it acts as both positive
and negative transcriptional regulator of hundreds of target genes
[44,45,46]. The genes putatively activated by MeCP2 code for
proteins involved in neuronal development, synaptic transmission
and neurotransmitter transport. Moreover, neuronal activity can
further modulate MeCP2 binding affinity to the DNA [47]. One of
the well established downstream targets of MeCP2 is the BDNF
gene [28,48,49]. BDNF expression can be upregulated by
overexpression of MeCP2 and down-regulated in MeCP2-null
animals [44,50]. BDNF knockout mice share many overlapping
phenotypes with MeCP2 knockout mice, including smaller brain
size, reduced dendritic arbor complexity and impaired synaptic
plasticity. Moreover, BDNF overexpression in the MeCP2 mutant
brain reverses some deficits observed in MeCP2 mutants [51,52],
suggesting that MeCP2 affects neuronal functions in part through
a BDNF dependent mechanism. Our previous studies show that
BDNF plays crucial roles during Xenopus retinotectal circuit
Figure 7. Expression of hMeCP2 differentially influences dendritic branching and postsynaptic site differentiation. The effects of
MeCP2 overexpression on postsynaptic specializations in the tectal neuron dendritic arbors are shown by the bar graphs. (A) The absolute number of
PSD95-GFP postsynaptic clusters in the hMeCP2-expressing neurons is lower than in controls both at 0 and 24 h. (B) When normalized per unit arbor
length, the density of PSD95-GFP postsynaptic clusters is similar to controls at the initial observation time point but increases significantly more than
controls by 24 hours. (C) hMeCP2-expressing neurons increase their postsynaptic clusters number by approximately two-fold in 24 hours.
Significance * p#0.05; ** p#0.005, ***p#0.001.
doi:10.1371/journal.pone.0033153.g007
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axon arbor branching and maintenance [31,53,54]. Here, we
demonstrate that MeCP2 participates in morphological and
synaptic development of tectal neurons in a cell autonomous
way. While manipulations in BDNF levels or BDNF receptor
signaling do not directly influence dendritic arborization of tectal
neurons [30,31], it is possible that MeCP2 influences tectal
neurons and retinotectal circuit development, at least in part,
through a BDNF-mediated mechanism as tectal neurons express
BDNF [55]. Consistent with this possibility, morpholino antisense
oligonucleotide downregulation of MeCP2 expression resulted in
altered BDNF expression in the Xenopus eye and midbrain, but did
not influence the expression of the BDNF receptor TrkB (A.H.K.
and S.C-C, unpublished).
Our finding that MeCP2 impacts neuronal cytoarchitecture and
connectivity in the amphibian brain indicates that MeCP2
function during neuronal development is conserved. How MeCP2
dysfunction impacts the morphological development of neurons,
however, seems to depend on the type of neuron that is affected,
the developmental stage at which MeCP2 expression and function
are altered, and the particular brain region and species analyzed
[15]. A large body of evidence also indicates that MeCP2 gene
copy number, the type and penetrance of the identified mutations
(partial or complete loss-of function), and whether MeCP2 acts
cell- or non-cell-autonomously, are important determinants for
MeCP2 function [56]. Observations that overexpression of wild
type MeCP2 in cultured cortical neurons increases dendrite
branching and dendritic processes length while expression of a
mutant form of MeCP2 results in highly branched dendrites that
are short in length [24] indicate that the gain and loss of MeCP2
function may produce similar phenotypes, and support the notion
that the precise levels of MeCP2 are key determinants during the
morphological development of neurons. Our observation that
expression of a mutant form of human MeCP2 (MeCP2 R168X
mutation lacking the transcription repression domain of the
protein) above endogenous Xenopus MeCP2 levels did not influence
tectal neuron dendritic morphology or growth (S. Marshak, data
not shown) while overexpression of wild-type hMeCP2 signifi-
cantly impacted dendritic morphology, is also consistent with the
idea that the levels of functional MeCP2 protein within a neuron
are important for proper development and function, and that non-
functional mutations cannot substitute for endogenous MeCP2
during dendritogenesis. Increased MeCP2 expression can there-
fore have significant functional consequences for the morpholog-
ical and functional development of Xenopus central neurons as in
other vertebrate species. Indeed, increased MeCP2 copy number
caused by duplication and triplication of part of the Xq28
chromosome carrying the MeCP2 gene causes a neurodevelop-
mental disorder in boys that is characterized by severe mental
retardation. [4,5].
That MeCP2 can exert both cell-autonomous and non-cell-
autonomous effects on neurons has recently been suggested by
studies that analyzed mouse models of RTT with targeted
mutations of MeCP2 [57,58,59]. Consistent with a cell-autono-
mous role for MeCP2 is also evidence that Mecp2-null neurons
develop dendritic arborization defects when transplanted to a wild-
type cortex [60]. Evidence demonstrating that mosaic expression
of MeCP2 in brains of heterozygote female mutant mice results in
wild-type neurons with dendrites that are less branched also
supports non-cell autonomous effects of the MeCP2 mutation
[61]. Moreover, evidence that astrocytes and microglia also
express MeCP2 and that in the absence of MeCP2 expression
glia can influence the morphological development of neurons
point to a glial-mediated mechanism by which MeCP2 influences
neuronal development [62]. Collectively, our in vivo imaging
studies reveal a novel cell-autonomous effect of MeCP2, where
increased expression of MeCP2 significantly impacts the morpho-
logical differentiation of affected central neurons and in turn
influences their synaptic connectivity. It is also possible, however,
that MeCP2 expression in the Xenopus central nervous system may
affect neuronal development and function in both cell-autonomous
and non-cell-autonomous ways as is the case in the mammalian
brain [61]. Potential non-cell autonomous roles for MeCP2, and
the mechanisms and interactions between MeCP2 function and
BDNF during retinotectal circuit formation are intriguing
possibilities that remain open for investigation.
In conclusion, by using an in vivo model system in which
manipulations can be spatially and temporally controlled to
examine the consequence of altered MeCP2 gene expression our
studies demonstrate that MeCP2 exerts direct, cell-autonomous
effects during the morphological and synaptic differentiation of
Xenopus central neurons. These studies support the idea that
MeCP2 gene dosage is important for proper neuronal differenti-
ation and maintenance, as alterations in MeCP2 expression can
lead to significant early defects in the growth and differentiation of
individual neurons, thus impacting their connectivity in an
otherwise intact brain.
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